NASDAQ:JSPR

Jasper Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy JSPR

*Your capital is at risk

$0.799

+0.0899 (+12.67%)

At Close: Aug 10, 2026

Jasper Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.05. In total, the insiders bought 4.2M and sold 5.4K JSPR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.05
● Buy	4.2M shares
● Sell	5.4K shares
94% Buy Activity Strong Negative Correlation
Buy Signal High Confidence Jul 16, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.05. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (94% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 31, 2026 Buy	Stock Option (Right to Buy A-Award	Wiggans Thomas G Director	Director	7 500 Value: $5K
Jul 31, 2026 Buy	Stock Option (Right to Buy A-Award	Lucas Svetlana Director	Director	7 500 Value: $5K
Jul 31, 2026 Buy	Stock Option (Right to Buy A-Award	Crutcher Patrick J Director	Director	7 500 Value: $5K
Jul 31, 2026 Buy	Stock Option (Right to Buy A-Award	Emster Kurt Von Director	Director	7 500 Value: $5K
Jul 31, 2026 Buy	Stock Option (Right to Buy A-Award	Shizuru Judith Anne Director	Director	7 500 Value: $5K
Jul 20, 2026 Buy	Non-Voting Convertible Preferred Stock P-Purchase	Ros Matthew E Chief Operating Officer	C-Suite Officer	881 Value: $717
Jul 20, 2026 Buy	Non-Voting Convertible Preferred Stock P-Purchase	Crutcher Patrick J Director	Director	888 Value: $723
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Keenan Greg Chief Medical Officer	Officer	92 278 Value: $56.3K
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Keenan Greg Chief Medical Officer	Officer	103 204 Value: $1K
Jul 16, 2026 Buy	Stock Options (Right to Buy)	Ros Matthew E Chief Operating Officer	C-Suite Officer	92 278 Value: $56.3K
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Ros Matthew E Chief Operating Officer	C-Suite Officer	103 204 Value: $1K
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Song Wenru EVP, Head Of R&d	Officer	5 262 Value: $1.15M
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Song Wenru EVP, Head Of R&d	Officer	1 764 Value: $304.5K
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Song Wenru EVP, Head Of R&d	Officer	563 Value: $93.4K
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Song Wenru EVP, Head Of R&d	Officer	5 885 Value: $21.1K
Jul 16, 2026 Buy	Voting Common Stock	Song Wenru EVP, Head Of R&d	Officer	0 Value: $0
Jul 16, 2026 Buy	Non Voting Convertible Preferred Stock	Song Wenru EVP, Head Of R&d	Officer	0 Value: $0
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Song Wenru EVP, Head Of R&d	Officer	630 Value: $2K
Jul 16, 2026 Buy	Stock Option (Right to Buy)	Song Wenru EVP, Head Of R&d	Officer	1 973 Value: $6K
Jul 16, 2026 Buy	Non-Voting Convertible Preferred Stock	Crutcher Patrick J Director	Director	463 452 Value: $358.7K
Jul 16, 2026 Buy	Stock Option (Right to Buy A-Award	Crutcher Patrick J Director	Director	15 000 Value: $11.6K
Jul 16, 2026 Buy	Voting Common Stock	Crutcher Patrick J Director	Director	0 Value: $0
Feb 06, 2026 Buy	Stock Option (right to buy) A-Award	Mahal Jeetinder Singh CEO And President	CEO / President	500 000 Value: $675.0K
Jan 02, 2026 Buy	Stock Option (right to buy) A-Award	Cross Herb Chief Financial Officer	C-Suite Officer	90 000 Value: $165.6K
Jan 02, 2026 Buy	Stock Option (right to buy) A-Award	Mahal Jeetinder Singh Chief Operating Officer	C-Suite Officer	90 000 Value: $165.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT JASPER THERAPEUTICS, INC.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The co...

Read Full Profile Here